Companies included in OZEM
This is OZEM's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–27 of 27.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| LLY | Eli Lilly & Co | 9,003 | NS | 16.09799% |
| NVO | Novo Nordisk A/S | 183,834 | NS | 13.133738% |
| Mount Vernon Liquid Assets Portfolio, LLC | Mount Vernon Liquid Assets Portfolio, LLC | 6,243,130.25 | NS | 12.136894% |
| PFE | Pfizer Inc | 138,419 | NS | 7.556105% |
| VKTX | Viking Therapeutics Inc | 83,569 | NS | 5.286496% |
| IVBXF | Innovent Biologics Inc | 242,500 | NS | 5.10502% |
| 1672 | Ascletis Pharma Inc | 1,133,000 | NS | 4.674781% |
| AMGN | Amgen Inc | 5,762 | NS | 3.941268% |
| ROP | Roche Holding AG | 5,146 | NS | 3.917949% |
| AZN | AstraZeneca PLC | 9,819 | NS | 3.764639% |
| 128940 | Hanmi Pharm Co Ltd | 5,593 | NS | 3.655928% |
| ZLDPF | Zealand Pharma A/S | 40,685 | NS | 3.597698% |
| 4519 | Chugai Pharmaceutical Co Ltd | 32,800 | NS | 3.451356% |
| REGN | Regeneron Pharmaceuticals Inc | 2,218 | NS | 3.331531% |
| 2196 | FOSUN PHARMA | 662,500 | NS | 3.255874% |
| 1093 | CSPC Pharmaceutical Group Ltd | 1,298,000 | NS | 2.92883% |
| GUBRA | Gubra A/S | 22,723 | NS | 2.418034% |
| GPCR | Structure Therapeutics Inc | 25,378 | NS | 2.377988% |
| 3933 | UNITED LAB | 954,000 | NS | 2.273264% |
| MBX | MBX Biosciences Inc | 34,264 | NS | 1.988326% |
| GILD | Gilead Sciences Inc | 7,043 | NS | 1.908236% |
| RYTM | Rhythm Pharmaceuticals Inc | 8,463 | NS | 1.430866% |
| SGIOF | Shionogi & Co Ltd | 32,700 | NS | 1.386163% |
| BHVN | Biohaven Ltd | 53,094 | NS | 0.873215% |
| FGXXX | First American Government Obli | 388,152.99 | NS | 0.754585% |
| WVE | WaVe Life Sciences Ltd | 32,778 | NS | 0.461983% |
| CRBP | Corbus Pharmaceuticals Holding | 22,131 | NS | 0.403991% |
SEC N-PORT snapshot as of .